About CIMERLI
CIMERLI was founded in 2020 and is based in Redwood City, United States. The company operates in the pharmaceutical sector, focusing on a website that delivers details about its product for infection injections. Leadership is provided by founder and CEO Dennis M. Lanfear. Operations center on informational resources for healthcare professionals and patients regarding treatment options and usage guidelines in the U.S. market.
- Headquarter Redwood City, United States
- Founders Dennis M Lanfear
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Sandoz, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CIMERLI
Detailed funding history for CIMERLI
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in CIMERLI
CIMERLI has secured backing from 1 investor. Prominent investors backing the company include Sandoz.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Generic and biosimilar pharmaceuticals are developed and distributed globally.
|
Locked | Locked | Locked |
Investor details for CIMERLI
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CIMERLI
Investment portfolio details for CIMERLI
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CIMERLI
Detailed financials for CIMERLI
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cimerli Comparisons
Peer comparison for CIMERLI
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CIMERLI
Detailed competitors of CIMERLI
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cimerli
Complete news archive for CIMERLI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CIMERLI
CIMERLI was founded in 2020.
CIMERLI is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Dennis M Lanfear is the current CEO of CIMERLI. They have also founded this company.
CIMERLI was founded in 2020 and is based in Redwood City, United States. The company operates in the pharmaceutical sector, focusing on a website that delivers details about its product for infection injections. Leadership is provided by founder and CEO Dennis M. Lanfear. Operations center on informational resources for healthcare professionals and patients regarding treatment options and usage guidelines in the U.S. market.
CIMERLI has 1 investor. Key investors include Sandoz.